What is BCR‑ABL fluorescence in situ hybridization (FISH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is BCR-ABL FISH?

BCR-ABL fluorescence in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescently-labeled DNA probes to detect the BCR-ABL gene fusion—the hallmark genetic abnormality in chronic myeloid leukemia (CML) and some acute lymphoblastic leukemias (ALL)—directly in cells without requiring them to divide.

Technical Overview

BCR-ABL FISH works by applying specific DNA probes that bind to the BCR gene on chromosome 22 and the ABL gene on chromosome 9. When the Philadelphia chromosome translocation t(9;22)(q34;q11) occurs, these genes fuse together, creating the BCR-ABL oncogene 1. The test can be performed on:

  • Metaphase cells (dividing cells with visible chromosomes)
  • Interphase cells (non-dividing cells), which is particularly valuable when cells fail to divide in culture or when rapid results are needed 2, 3

Probe Types and Their Performance

Two main probe designs exist, with significantly different accuracy profiles:

Dual Fusion Probes (Superior)

  • Visualize TWO fusion signals: BCR-ABL and ABL-BCR
  • False positive rate: 0.19% ± 0.12%
  • False negative rate: 0.4%
  • Recommended as the preferred approach 1, 4

Extra Signal (ES) Probes (Inferior)

  • Visualize ONE fusion signal
  • False positive rate: 4.5% ± 2.3%
  • False negative rate: 13.5%
  • Higher error rates due to random spatial association of signals in normal cells 4

The dual fusion probe design is strongly recommended because it dramatically reduces both false positives and false negatives 1.

Clinical Applications

At Diagnosis

BCR-ABL FISH is mandatory in specific situations 1:

  • When insufficient metaphases are obtained for conventional cytogenetics
  • When karyotype appears normal but CML is clinically suspected (to detect cryptic rearrangements)
  • When variant translocations are detected (to confirm BCR-ABL fusion)
  • For rapid preliminary testing using direct harvest or smears

During Treatment Monitoring

FISH can replace chromosome analysis for monitoring treatment response once complete cytogenetic response is achieved 1. However, there's an important caveat: cases showing only a single fusion signal at diagnosis cannot be reliably monitored by FISH 1.

Detection Threshold

The cutoff for specific BCR-ABL fusion signals is typically set at 9.0% (three times the standard deviation above background), as normal reactive bone marrow shows nonspecific signals at approximately 2.7% 3. This threshold limitation means FISH has reduced sensitivity for detecting minimal residual disease below 9% 3.

Signal Pattern Interpretation

Most BCR-ABL+ patients (83%) display typical FISH patterns 2:

  • Major BCR-ABL (M-BCR): 87% of CML cases
  • Minor BCR-ABL (m-BCR): 48% of ALL cases

Atypical patterns occur in 17% of cases and may indicate 2:

  • Additional Philadelphia chromosomes (7%)
  • Deletions of 9q sequences proximal to breakpoint (8%)
  • Deletions of 22q sequences distal to breakpoint (5%)
  • Gain or loss of chromosomes 9 or 22
  • Cryptic insertions

When atypical patterns are detected, metaphase FISH and molecular breakpoint analysis are required for precise interpretation 2.

Validation Requirements

Each FISH test must be validated separately for different tissue types (conventional cytogenetic preparations vs. paraffin-embedded tissues require separate validations) 5. Probe localization should be confirmed by scoring a minimum of five metaphase cells, preferably from male subjects to exclude Y chromosome cross-hybridization 5.

Advantages Over Conventional Cytogenetics

  • Faster results: Can be performed on interphase cells without waiting for cell division 3, 6
  • Higher success rate: Particularly valuable in treated patients where cytogenetics often fails (successful in only 27 of 42 treated CML patients vs. FISH success in nearly all) 3
  • Detects cryptic rearrangements: Identifies BCR-ABL fusions not visible by standard karyotyping 1, 6
  • Large cell numbers: Allows analysis of hundreds to thousands of cells when hybridization efficiency is optimal 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.